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Summary
Aromatic amino acid ammonia-lyases catalyze the
deamination of L-His, L-Phe, and L-Tyr, yielding
ammonia plus aryl acids bearing an a,b-unsaturated
propenoic acid. We report crystallographic analyses
of unliganded Rhodobacter sphaeroides tyrosine am-
monia-lyase (RsTAL) and RsTAL bound to p-couma-
rate and caffeate. His 89 of RsTAL forms a hydrogen
bond with the p-hydroxyl moieties of coumarate and
caffeate. His 89 is conserved in TALs but replaced in
phenylalanine ammonia-lyases (PALs) and histidine
ammonia-lyases (HALs). Substitution of His 89 by
Phe, a characteristic residue of PALs, yields a mutant
with a switch in kinetic preference from L-Tyr to L-Phe.
Structures of the H89F mutant in complex with the
PAL product, cinnamate, or the PAL-specific inhibitor,
2-aminoindan-2-phosphonate (AIP), support the role
of position 89 as a specificity determinant in the family
of aromatic amino acid ammonia-lyases and amino-
mutases responsible for b-amino acid biosynthesis.
Introduction
Tyrosine ammonia-lyase (TAL) catalyzes the nonoxida-
tive elimination of ammonia from L-Tyr, yielding trans-
p-coumaric acid (trans-p-hydroxycinnamic acid). TAL
is a member of a family of ammonia-lyases that de-
aminate the aromatic amino acids, L-His, L-Phe, and
L-Tyr (Figure 1) (reviewed in [1]). In plants and fungi,
a dedicated TAL has not been identified, but instead
phenylalanine ammonia-lyase (PAL) occurs widely.
PAL produces trans-cinnamic acid, leading to a variety
of specialized phenolic plant and fungal metabolites.
PAL from dicotyledonous plants efficiently deaminates
L-Phe, while PAL from some monocots including maize
efficiently deaminates both L-Phe and L-Tyr [2]. Simi-
larly, PAL from the yeast Rhodosporidium toruloides
turns over both L-Phe and L-Tyr [3]. Thus, PAL-derived
TAL activity in monocots and fungi provides an alterna-
tive route to the phenylpropanoid precursor p-coumaric
acid, in lieu of hydroxylation of cinnamic acid by the
*Correspondence: noel@salk.edumembrane-bound cytochrome-P450 monooxygenase,
cinnamate-4-hydroxylase.
In bacteria, phenylpropanoids are rare, and accord-
ingly PAL and TAL are poorly represented (at least
based upon gene annotation). To date, PALs have
been identified in Streptomyces maritimus [4], Photo-
rhabdus luminescens [5], Sorangium cellulosum [6],
and Streptomyces verticillatus [7]. In these bacteria,
the PAL product cinnamic acid serves as an intermedi-
ate in the biosynthesis of antibiotic or antifungal com-
pounds (enterocin, 3,5-dihydroxy-4-isopropyl-stilbene,
soraphen A and cinnamamide). PALs have also been
identified in Anabaena variabilis and Nostoc puncti-
forme, although the ultimate fate of cinnamic acid
in these cyanobacteria is currently unknown (M.C.M.,
unpublished data). The only confirmed bacterial sources
of TAL are several species of purple phototropic bacteria
(Rhodobacter capsulatus, Rhodobacter sphaeroides,
and Halorhodospira halophila), in which p-coumarate is
a precursor of the chromophore of photoactive yellow
protein [8, 9], and the actinomycete Saccharothrix espa-
naensis [10], where coumarate is used for saccharomicin
antibiotic biosynthesis.
The aromatic amino acid ammonia lyases contain a
4-methylidene-imidazole-5-one (MIO) cofactor formed
by the spontaneous (autocatalytic) cyclization and de-
hydration of an internal Ala-Ser-Gly tripeptide segment
[11]. Two alternative mechanisms have been suggested
for the role of the electrophilic MIO cofactor in catalyzing
the elimination of the a-amino group and the stereo-
specific abstraction of a b-proton from the L-amino
acid substrate [12, 13]. Both mechanisms are intensely
debated and must account for the activity of the recently
characterized tyrosine- and phenylalanine amino-
mutases (TAM and PAM, respectively) [14–16]. These
MIO-dependent enzymes are closely related to the aro-
matic amino acid ammonia-lyases forming intermediate
aryl acids, but they ultimately catalyze a second reactive
step in which the a-amino group removed from the sub-
strate is transferred to the b-carbon, yielding a b-amino
acid product (Figure 1).
Crystal structures are available for PALs from R. toru-
loides [13, 17] and Petroselinum crispum [18], as well as
histidine ammonia-lyase (HAL) from the bacterium
Pseudomonas putida [19]. Nevertheless, the enzymatic
mechanism and determinants of substrate specificity
of the aromatic amino acid ammonia-lyases remain to
be fully defined. Earlier studies have been hindered in
part by a lack of accurate information pertaining to the
mode of substrate/product binding. We now report the
crystal structure of TAL from the bacterium R. sphaer-
oides. The structure provides a unique view of an
aromatic amino acid ammonia-lyase with a kinetic
preference for L-Tyr. We also describe the structures
of TAL complexed with the products of the TAL-cata-
lyzed reactions using L-Tyr and L-DOPA substrates,
namely p-coumaric and caffeic acids, respectively.
These structures provide definitive views of the binding
of products to aromatic amino acid ammonia-lyases,
thus identifying the substrate selectivity determinants
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these high-resolution structures, RsTAL was success-
fully engineered into a kinetically authentic PAL, and ad-
ditional structures of mutant RsTAL were obtained with
the product of the PAL-catalyzed reaction using L-Phe
as a substrate, namely cinnamic acid and with the
PAL-specific inhibitor, AIP.
Results and Discussion
X-Ray Crystal Structure of R. sphaeroides TAL
The monoclinic crystal form (space group P21) of
R. sphaeroides TAL (RsTAL) contains two complete
Figure 1. Reactions Catalyzed by the Aromatic Amino Acid Ammo-
nia-Lyases and the Related Aminomutases
Tyrosine ammonia-lyase (TAL), phenylalanine ammonia-lyase
(PAL), and histidine ammonia-lyase (HAL) catalyze the nonoxidative
deamination of their respective amino acid substrates, yielding the
corresponding a-b unsaturated aryl-acid product plus ammonia.
The aminomutases catalyze the a-b migration of the amino group
of the a-amino acid substrate. Labeling experiments [1, 15] have
shown that the yellow b-proton (pro-S in L-Phe and L-Tyr, pro-R
in L-His) of the substrate is stereospecifically abstracted. The
dashed arrows emphasize the intermediacy of the lyase reaction
in the overall reaction catalyzed by the aminomutases, which
invoke Michael addition of ammonia to Cb of the aryl-acid inter-
mediate [1, 14–16].homotetramers of the polypeptide chain per asymmetric
unit. The initial structure solution was obtained by mo-
lecular replacement, with a search model derived from
a tetramer of PpHAL (PDB entry 1GKM). The rotation
function identified two orientations for the tetramer,
with peak heights of 13.4 and 12.5 s; translation-
function searches then positioned the two tetramers,
with an R factor/correlation coefficient of 0.524/0.146
for the first tetramer and, subsequently, 0.514/0.182
for the second tetramer. The atomic model of RsTAL
was refined to 1.50 A˚ resolution (Table 1). The two tetra-
mers of RsTAL are nearly identical, as the root-mean-
squared positional deviation (rmsd) between equivalent
backbone atoms is only 0.12 A˚. The eight distinct mono-
mers also exhibit nearly identical backbone conforma-
tions; for pair-wise comparisons between individual
monomers, the rmsd values range from 0.10 to 0.18 A˚.
Only residues 1 to 7 and the C-terminal residue 523 of
each of the eight RsTAL monomers are poorly ordered
in electron-density maps.
Structure of RsTAL
Both the tertiary and quaternary structures (Figures 2A
and 2B) of RsTAL are similar to those described previ-
ously for related ammonia-lyases, PpHAL (PDB entry
1GKM), and PALs from parsley (P. crispum; 1W27) and
yeast (R. toruloides; 1T6P, 1Y2M). These proteins form
homotetrameric oligomers with 222-point symmetry.
The homotetramer contains four active sites, with three
distinct monomers participating in formation of each ac-
tive-site cavity. Each monomer adopts a predominantly
a-helical fold (Figure 2B), organized around an up-down
bundle of five a helices. The flanking regions of these he-
lices, together with the extended hairpin loop linking he-
lices 4 and 5 of the helical bundle, are responsible for
forming the monomer-monomer interfaces at the core
of the tetramer. The N-terminal region of the polypeptide
chain contributes to a domain that carries the MIOTable 1. Summary of Data Collection and Refinement Statistics
RsTAL
Unliganded
RsTAL-
Coumarate
RsTAL-
Caffeate
H89F TAL-
Cinnamate
H89F TAL-
Coumarate H89F TAL-AIP
Space group P21
Unit cell parameters
a (A˚) 87.9 87.4 87.6 87.6 87.6 87.6
b (A˚) 155.5 154.8 155.0 155.0 155.0 154.8
c (A˚) 164.3 164.1 164.2 164.0 164.1 164.5
b () 94.1 94.1 94.1 94.2 94.1 94.2
Monomers per asymmetric unit 8
Resolution rangea (A˚) 100–1.50
(1.58–1.50)
100–1.58
(1.68–1.58)
100–1.90
(2.00–1.90)
100–1.90
(2.00–1.90)
100–2.00
(2.10–2.00)
100–1.75
(1.84–1.75)
Number of reflections measured 3,870,665 1,901,422 1,195,768 1,133,848 891,554 1,396,599
Merging R factora 0.085 (0.618) 0.068 (0.570) 0.112 (0.546) 0.135 (0.511) 0.139 (0.503) 0.089 (0.487)
Mean (I/s I)a 12.2 (2.3) 15.6 (2.0) 8.5 (2.4) 7.5 (2.2) 7.5 (2.5) 9.3 (1.9)
Completenessa 0.933 (0.859) 0.873 (0.494) 0.989 (0.975) 0.992 (0.973) 0.962 (0.959) 0.964 (0.822)
Redundancya 5.9 (3.6) 3.7 (2.7) 3.5 (3.4) 3.3 (2.6) 3.2 (2.7) 3.3 (2.2)
Number of reflections used 644,928 509,395 338,602 337,722 282,486 420,387
R factora 0.174 (0.254) 0.192 (0.298) 0.175 (0.253) 0.172 (0.265) 0.172 (0.247) 0.189 (0.293)
Free R factora 0.189 (0.276) 0.208 (0.319) 0.198 (0.283) 0.196 (0.285) 0.201 (0.281) 0.210 (0.321)
Number of amino acid residues 4,130 4,130 4,130 4,130 4,130 4,130
Number of water molecules 3,914 3,482 3,224 3,288 3,110 3,089
Residues with most favorable
conformation (%)
93.3 93.4 93.4 93.0 93.1 92.9
Merging R factor =
P
hkl
P
i j Ii(hkl) 2 hI(hkl)i j/
P
hkl
P
i Ii(hkl).
a Values in parentheses describe the highest resolution shell.
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1329cofactor (Figure 2B), and at the opposite end of the bun-
dle, the C-terminal segment forms a peripheral a-helical
layer. The C-terminal domain participates in additional
intersubunit contacts that stabilize the homotetramer,
and it provides the outer-lid loop (Figures 2B and 2C,
and discussion below), which caps the active-site cavity
of an adjacent monomer. Like bacterial HAL, RsTAL
lacks an additional domain that is inserted into the C-ter-
minal domain of both yeast and parsley PAL. The func-
tion of this additional domain is uncertain; regulatory
roles in shielding access to the active-site tunnel [18]
or modulating the flexibility of an active-site lid loop
[20] have been suggested as functional roles.
From a comparison of the superposed polypeptide-
chain backbones of the known ammonia-lyase struc-
tures, RsTAL differs from P. putida HAL by 1.9 A˚ rmsd
for 464 equivalent residues (with 34% sequence iden-
tity), from parsley PAL by 2.0 A˚ rmsd for 445 equivalent
residues (with 27% sequence identity), and from yeast
PAL by 1.9 A˚ rmsd for 446 equivalent residues (with
30% sequence identity). The greater overall structural
similarity ofRsTAL with the bacterial HAL, in comparison
to the eukaryotic PALs, is consistent with the higher
overall sequence identity of RsTAL with the bacterial
HALs and the absence of additional polypeptide
segments (at the N terminus and within the shielding
domain) that occur in the eukaryotic PALs. These
characteristics have led to suggestions that TAL and
eukaryotic PAL diverged from bacterial HAL in separate
evolutionary lineages [18].
Methylidene-Imidazolone Cofactor of RsTAL
The MIO cofactor of RsTAL, formed by Ala 149, Ser 150,
and Gly 151, resides in well-defined electron density
(Figure 2D). The imidazolone ring stacks against the
side chain of Phe 353. The MIO N2 atom, derived from
Ser 150, accepts hydrogen bonds from the hydroxyl
moiety of Tyrd300 and the side-chain amide of Gln 436.
Residue numbering refers to the polypeptide chain of
a single monomer designated ‘‘a’’; residues designated
with superscripted ‘‘b,’’ ‘‘c,’’ or ‘‘d’’ are contributed by
one of the dyad-related monomers of the homotetramer.
The MIO keto group oxygen, O2 , sits in a pocket lined by
the backbone amides of Leu 153 and Gly 204 (the oxyan-
ion hole, see below) but does not make any direct con-
tacts with protein residues and instead forms a hydrogen
bond with a water molecule (Figure 2D).
MIO appears to carry an adduct attached to the elec-
trophilic methylidene carbon Cb2 (Figure 2D). The pre-
cise identity of this adduct is uncertain, but likely corre-
sponds to the covalent attachment of an ammonium
group. This posited adduct supports MIO derivatization
by ammonia derived from ammonium acetate used for
crystallization and present at 0.3 M. The presence of
a nucleophilic adduct is supported by the planar sp2
configuration of the MIO N3 atom, associated with
aromaticity of the imidazolone ring. Similarly, crystal
structures of other ammonia-lyases bearing a covalent
adduct indicate sp2 hybridization of N3 [13, 18, 19, 21].
In contrast, in structures of both PAL [17] and HAL [19]
with unmodified MIO, the N3 atom assumes an sp3
hybridization state, indicative of a nonaromatic imidazo-
lone ring.Binding of Coumarate and Caffeate Reaction
Products to RsTAL
The binding of coumarate observed in RsTAL crystals
supports product inhibition of the ammonia-lyases
[22]. However, attempts to complex L-Tyr or observe
turnover of L-Tyr in RsTAL crystals were unsuccessful.
The high concentration of ammonium ion in the crystal-
lization medium and the attendant covalent modification
of MIO likely prevent both L-Tyr binding and TAL activity
in crystals. Notably, HAL and PAL samples bearing
modified cofactors are catalytically inactive [18, 19]. In
crystal soaking experiments of RsTAL with the PAL
product cinnamic acid or the PAL-specific inhibitor, 2-
aminoindan-2-phosphonic acid (AIP) [23], no significant
binding was observed, in accord with the poor turnover
of L-Phe by RsTAL and the weak inhibition of RsTAL ac-
tivity by AIP (see discussion below and Table 2).
The RsTAL-coumarate cocrystal structure provides
eight independent views (per asymmetric unit) of the
enzyme-product complex. Notably, all of the protein
residues that form interactions with coumarate are in-
variant in the TALs functionally characterized to date
(Figure 3A). The coumarate conformation and interac-
tions with RsTAL are nearly identical in the eight
copies of the complex in the asymmetric unit. In terms
of the observed propenoate conformation, the alkene
double bond is not conjugated with either the hydroxy-
phenyl ring (approximately 30 out of plane) or the car-
boxylate group (approximately 50 out of plane). Most
notably, in all eight instances, the same (si) face of
the alkene double bond is directed toward MIO. The
hydroxyphenyl ring of coumarate is roughly orthogonal
to the plane of MIO. The closest approach to the electro-
philic methylidene carbon of MIO—3.6 A˚—is by the cou-
marate carbon atom equivalent to the Cb atom in the
L-Tyr substrate (Figure 3B).
The carboxylate group of the propenoate moiety
forms hydrogen bonds with the side-chain amide of
Asn 435 and a salt bridge with the d-guanido group of
Argd303 from the dyad related polypeptide chain. The
aliphatic portion of the propenoate segment packs
against two residues from the inner lid-loop, Tyr 60
and Gly 67. The nonpolar side chains of Leu 90, Leu
153, and Metb405, and the hydrophilic side chains of
Asn 432 and Gln 436 surround the phenyl ring of the
bound coumarate. Finally, the p-hydroxyl group of
the hydroxyphenyl ring forms hydrogen bonds with the
side chain of His 89 and a water molecule that resides
in a hydrogen-bonding network involving four other
water molecules (Figure 3B). Caffeic acid carries an
additional meta-hydroxyl group on the phenyl ring, and
the crystal structure of the complex with RsTAL demon-
strates that this hydroxyl moiety sits in the space resid-
ing above the cofactor (Figure 3C). Caffeic acid is
the product of the deamination of the a-amino-acid
L-DOPA (3,4-dihydroxy-L-Phe), and, interestingly,
RsTAL exhibits activity with L-DOPA (data not shown).
The L-shaped active-site cavity is only partially filled
by coumarate and extends above the methylidene car-
bon of MIO and into space occupied by the network of
water molecules described above (Figures 3B and 3D).
The excess space in the vicinity of the coumarate
binding site is available to phenyl rings with larger sub-
stituents, as shown for the caffeic acid complex (Figures
Chemistry & Biology
1330Figure 2. Three-Dimensional Structure of RsTAL
(A) Ribbon representations of the RsTAL homotetramer, with the polypeptide chains of the individual monomers colored green (a), cyan (b),
magenta (c), and yellow (d). The atoms of the four MIO cofactors are drawn as color-coded van der Waals spheres with red for oxygen, light
gray for carbon, and blue for nitrogen. Orthogonal views from the top (left) and front (right) of the homotetramer are shown. The 222-point
symmetry of the homotetramer is generated by three mutually orthogonal and intersecting 2-fold rotational axes, shown as gray lines. In
each orientation, two of the axes are visible, with the third axis perpendicular to the page.
(B) Ribbon representation of the RsTAL monomer. The polypeptide chain is colored according to a gradient, with blue and red serving as
extremes for the N- and C termini, respectively. The atoms of the MIO cofactor formed by the tripeptide segment Ala 149-Ser 150-Gly 151
are drawn as balls and sticks color-coded by atom type. The 2-fold axes that relate this monomer to the other monomers in the homotetramer
are shown as gray lines.
(C) Electron density and interactions of the active-site lid loops of RsTAL complexed with coumarate shown as a stereo pair. The three-
stranded b sheet is shown at the upper left. Three residues of the inner loop, Tyr 60, Phe 66, and Gly 67, encompass the bound coumarate
product. Backbone hydrogen-bonding interactions of the lid loop are shown as magenta dashed lines; hydrogen-bonding interactions involv-
ing coumarate are represented as green dashed lines. The blue-colored contours envelop regions greater than 1.0s in the final 2Fobs 2 Fcalc
electron-density map calculated at 1.58 A˚ resolution.
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1331Table 2. Kinetic Parameters for Wild-Type and H89F RsTAL and Comparison with Other TAL/PAL Enzymes
Enzyme [Reference] Substrate Km (mM) kcat (s
21) kcat /Km (s
21 mM 21) AIP Ki (mM)
WT RsTAL [this study] L-Tyr 74.2 4.32 0.058 NM
L-Phe 11,400 13.10 0.0011 16.3
H89F RsTAL [this study] L-Tyr NM NM NM NM
L-Phe 434 8.15 0.019 0.60
RcTAL [8] L-Tyr 15.6 27.7 1.77 ND
L-Phe 1277 15.1 0.0118 ND
SeTAL [10] L-Tyr 15.5 0.015 9.68 3 1024 ND
L-Phe 2,860 0.0038 1.3 3 1026 ND
ZmPAL [2] L-Tyr 19 0.9 0.0473 ND
L-Phe 270 10 0.037 ND
PcPAL [22] L-Tyr 2,500 0.3 1.2 3 1024 ND
L-Phe 17.2 22 1.28 0.025
SmPAL [4] L-Phe 23 0.0048 2.1 3 1023 1.81
PlPAL [5] L-Phe 320 0.8 2.5 3 1023 ND
Rc, Se, Zm, Pc, Sm, and Pl are R. capsulatus, S. espanaensis, Z. mays, P. crispum, S. maritimus, and P. luminescens, respectively. NM is not
measurable, and ND is not determined.3C and 3D). These results collectively raise intriguing
possibilities for the deployment ofRsTAL for in vivo gen-
eration of bioactive phenylpropanoids and for the ratio-
nal engineering of TALs to accept diverse amino-acid
substrates.
Previous crystallographic analyses of PAL and HAL
have yielded (with one exception) only unliganded en-
zyme structures, but these structures have served as
a starting point for predictive modeling of substrate-,
product-, and reaction-intermediate-bound states.
These docking attempts assumed attack on the MIO
methylidene-carbon by either the a-amino group or the
electron-rich aromatic ring of the substrate; and thus,
substrate docking targeted a conjectured relative
positioning of substrate and cofactor, as well as the for-
mation of favorable substrate-protein interactions.
Although some of these modeled complexes (in particu-
lar those described [1]) agree roughly with the binding
mode observed in the TAL-coumarate complex, in gen-
eral, the ligand-enzyme interactions have not been ac-
curately predicted. The mode of substrate/product
binding, in particular the positioning of the aromatic
ring, suggested most recently in Ritter and Schulz [18],
deviates significantly from the product complexes re-
ported here. This recent docking study was updated
from a previous model [19] to maximize interaction be-
tween the substrate and PcPAL-Phe 400. Ironically,
the previous model [19] more closely approximates the
experimentally determined complexes reported here.
A weakly bound cinnamate molecule described in
a crystal structure of R. toruloides PAL [13] was mod-
eled in a reverse orientation, with its phenyl and car-
boxylate groups approximately transposed relative to
those of coumarate bound to TAL. Finally, there is no
apparent involvement of metal ions in the RsTAL-
coumarate interaction, as proposed for HAL-substrate
interactions [24].The structures of RsTAL-coumarate and RsTAL-
caffeate complexes provide conclusive identification
of the active-site residues that form the binding pocket
for the product. Together with the pattern of amino
acid conservation of the substrate-recognition site (Fig-
ure 3A) and the results of site-directed mutagenesis [24,
25] of active-site residues, this structural information
provides a rational basis for interpreting the roles that
these residues play in determining substrate specificity
and in catalyzing the enzyme reactions.
Tyr 60, Gly 67, Tyr 300, and Arg 303 (RsTAL number-
ing), which interact with the backbone atoms of the
amino acid substrate, are highly conserved in HAL,
PAL, and TALs. Indeed, the salt bridge between the
Arg 303 d-guanido moiety and the substrate’s a-carbox-
ylate group served as an anchoring interaction in most of
the earlier modeling attempts. Replacement of this con-
served Arg with Ala in PAL [25] or Ile in HAL [24] caused
large decreases in enzyme activity, whereas a Lys sub-
stitution in HAL minimally affected activity [24]. Phe sub-
stitution of the Tyr corresponding to RsTAL Tyr 300 in
both HAL [24] and PAL [25] also resulted in significant
losses of activity. Tyr 60, from the inner-lid loop (see be-
low), likely resides near the Cb atom of the amino acid
substrates, and, consistent with a postulated role as
a general base for b-proton abstraction, substitution of
this Tyr by Phe severely debilitated enzyme activity for
both HAL [24] and PAL [25]. The residues that interact
with the aromatic ring of the substrate are more variable
among the ammonia-lyases, but are more similar be-
tween the PAL and TAL families than between these
two families and the HALs.
Notably, the His at the position corresponding to His
89 in RsTAL is found in other functionally characterized
bacterial TALs, as well as maize and yeast PALs, the lat-
ter of which possess significant TAL activity [2, 3]. In
contrast, in PALs, a Phe occurs almost invariably at(D) Methylidene-imidazolone (MIO) cofactor. MIO and protein residues are shown as balls and sticks colored by atom type. Hydrogen-bonding
interactions are represented as green dashed lines. An oxyanion hole is formed by the backbone amides of Leu 153 and Gly 204. The 149-150-
151 numbering indicates the amino acid origin of the MIO cofactor. The blue-colored contours envelop regions greater than 3s in the MIO-omit
Fobs 2 Fcalc electron-density map. The inset shows the atom nomenclature of the native MIO cofactor, with the atom names colored according
to atom type and numbered according to the originating residue within the 149–151 tripeptide (Ala 149 is 1, Ser 150 is 2 and Gly 151 is 3).
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(A) Partial amino acid (single letter codes) sequence alignment of RsTAL with representative members of the aromatic amino acid ammonia-
lyase family discussed in the text. Only regions that form the active site of the enzymes are shown. Numbering is according to RsTAL. Yellow
boxes highlight conserved catalytic and binding residues, while the green box highlights the specificity determining residues.
(B) Electron density and interactions of the coumarate product bound in the active site of wild-type RsTAL shown as a stereo pair. The cou-
marate, MIO cofactor, and protein side chains that line the active-site pocket are rendered as balls and sticks and colored according to atom
type. Hydrogen-bonding interactions are shown as green dashed lines. The blue-colored contours envelop regions greater than 2.5s in the
initial Fobs 2 Fcalc electron-density map calculated at 1.58 A˚ resolution with phases derived from the unliganded model. The closest atom
of coumarate to the MIO cofactor (labels colored green) is labeled Cb and colored red.
(C) Electron density and interactions of the caffeate product bound in the active site of wild-type RsTAL. The phenyl ring of caffeate adopts
primarily the conformation shown; a second, lower-occupancy conformation that differs only in the (inward) position of the meta-hydroxyl
group is also observed. The blue-colored contours envelop regions greater than 2.5s in the initial Fobs 2 Fcalc electron-density map calculated
at 1.90 A˚ resolution with phases derived from the unliganded model.
(D) Product binding pocket in RsTAL. The depicted surface represents the area accessible to a probe sphere 1.4 A˚ in radius and the surface is
color-coded according to the identity of the underlying protein atom (carbon is gray; nitrogen is blue; oxygen is red). The front portion of the
RsTAL tetramer has been cut away to reveal the internal cavity in the vicinity of the MIO cofactor. The coumarate molecule (shown in cyan) was
excluded in the calculation of the molecular surface. The position of a caffeate molecule bound to RsTAL is shown in yellow. MIO is labeled
(green) as shown in the inset of Figure 2D.the position equivalent to RsTAL His 89, and Phe would
support favorable nonpolar interactions with the phenyl
group of the L-Phe amino acid substrate. Furthermore,
the pivotal two-residue His-Leu sequence (89 and 90 in
RsTAL), which characterizes the TALs and is replaced
by Phe-Leu in the PALs, is instead Ser-His in the HALs
(Figure 3A). The HAL/PAL residue-substitution indicated
previously [19] resides not at RsTAL His 89 but at theposition adjacent to His 89 in RsTAL, namely Leu 90.
RsTAL Leu 90 corresponds to His 89 in PpHAL and Leu
138 in PcPAL [18]. Notably, the L138H mutant (together
with Q488E) was generated in PcPAL, but this double
mutant did not result in a switch from PAL to HAL activ-
ity, leading the authors to state that substrate specificity
preferences cannot be readily explained by amino acid
differences in the respective ammonia-lyases [1, 25].
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Preferences of RsTAL
These structures point toRsTAL His 89 as a key determi-
nant of the substrate specificity of the aromatic amino
acid ammonia-lyases. We reasoned that replacement
of His 89, which forms a favorable hydrogen bond with
the side-chain hydroxyl group of L-Tyr, with Phe would
result in considerable turnover of L-Phe. From an as-
sessment of the kinetic properties of the RsTAL mutants
(Table 2), wild-type RsTAL displays a marked kinetic
preference for L-Tyr, as both the Km (150-fold) and
kcat/Km (53-fold) are substantially better for L-Tyr as
compared to L-Phe. These values are similar to the
steady-state kinetic constants for the homologous TAL
from Rhodobacter capsulatus [8].
In contrast, the engineered RsTAL variant with the
single amino acid substitution H89F lacks activity with
L-Tyr and, as predicted, efficiently turns over L-Phe.
With L-Phe, the H89F point mutant exhibits a 26-fold de-
crease in Km and a 17-fold increase in kcat/Km compared
to wild-type RsTAL. Indeed, the catalytic efficiency of
the PAL activity for the H89F mutant (kcat/Km 0.019 s
21
mM21) is only slightly lower than that of TAL activity
for wild-type RsTAL (0.058 s21 mM21), and it exceeds
the catalytic efficiency of some native PALs (Table 2).
In addition, the differing kinetic specificities of the
wild-type and mutant RsTALs are further substantiated
by the relative susceptibilities to inhibition by AIP, a
PAL-specific inhibitor [23]. For wild-type RsTAL, activity
with L-Tyr is unaffected by AIP, whereas activity with L-
Phe is inhibited (Ki=16.3 mM). For the H89F mutant with
L-Phe, the Ki = 0.60 mM and is 27-fold lower (greater in-
hibitory activity) than for wild-type RsTAL.
We next determined crystal structures of the H89F
mutant complexed with the reaction product cinnamate
(Figure 4A), as well as with coumarate (Figure 4B) and
AIP (Figures 4C and 4D). The phenyl ring of Phe 89 oc-
cupies the same space as the His 89 imidazole ring of
wild-type RsTAL with little active site perturbation. Like-
wise, cinnamate aligns with coumarate bound to wild-
type RsTAL. The phenyl rings of cinnamate and Phe 89
are roughly coplanar and within van der Waals dis-
tances. Unexpectedly, binding of coumarate to the
H89F mutant was observed. The position and orienta-
tion of the bound coumarate differs from that observed
in wild-type RsTAL, relieving expected steric clashes
with protein side chains (Figure 4E). Moreover, elec-
tron-density maps indicate that the coumarate molecule
is poorly ordered in the H89F RsTAL active site. With the
H89F mutant, although the salt bridge between the cou-
marate carboxylate group and the d-guanido moiety of
Argd303 is preserved, the p-hydroxyl group is pushed
away from the phenyl ring of Phe 89 and lacks a hydro-
gen-bonding partner. Moreover, the opposite face of the
propenoate portion of coumarate is oriented toward the
MIO cofactor (Figure 4B). This disrupted binding mode
likely explains the inactivity of the H89F RsTAL mutant
with L-Tyr as substrate.
Most intriguing is the complex of the H89F mutant with
AIP, in which the amino group of the inhibitor covalently
attaches to the methylidene carbon of MIO (Figures 4C
and 4D). Analogous to the cinnamate complex (Fig-
ure 4A), the salt bridge between the Argd303 d-guanido
moiety and the carboxylate mimic, namely the phospho-nate group of AIP, and the edge-edge interaction be-
tween the phenyl rings of AIP and Phe 89 occur in a
conserved fashion. However, because of the covalent
attachment of the AIP moiety to the cofactor, the relative
positions of AIP atoms with respect to TAL residues dif-
fer in comparison to cinnamate (Figures 4A and 4D).
Furthermore, the formation of the covalent AIP adduct
causes a significant rearrangement of a nearby segment
of the polypeptide-chain-spanning residues 194–205
and points to possible mechanistic roles for some of
these residues.
Active-Site Loops of RsTAL
In previously published HAL and PAL crystal structures,
two loops situated near the entrance to the active sites
exhibit high mobility, as evidenced by the variability in
loop conformations, high crystallographic temperature
factors, complete disorder, and the presence of proteo-
lytically sensitive cleavage sites [13, 17–19]. Flexibility of
these loops has been suggested to be a functional re-
quirement for substrate binding and catalysis [20]. One
active-site loop, termed the inner lid-loop, originates
from the MIO domain of the same polypeptide chain
that provides the MIO cofactor, and it contains a num-
ber of highly conserved residues. The second loop (the
outer lid-loop) projects from the C-terminal domain
of a dyad-related monomer in the homotetramer. The
RsTAL structure is unique in that these lid loops are
not only well ordered but form a compact arrangement
within the active-site cavity (Figures 2C and 5A).
Three Gly residues, 61, 65, and 67, facilitate formation
of several interactions in this region, including a short
three-stranded b sheet, which involves polypeptide seg-
ments from both the inner and outer lid-loops (Fig-
ure 5B). The environment of MIO in RsTAL is therefore
sequestered from the bulk solvent, in contrast to the
relatively open active-site access observed in other
aromatic amino acid ammonia-lyase structures with dis-
ordered or more externally positioned lid loops. In the
structure of the RsTAL-coumarate complex, the inner
lid-loop comes in close contact with the coumarate mol-
ecule (Figures 2C and 3B).
In previous crystallographic studies of aromatic
amino acid ammonia-lyases, attempts to obtain com-
plexes with substrate or product were unsuccessful.
Our observation of well-ordered coumarate binding in
RsTAL crystals is likely due to the positioning of the lid
loops. Substrate binding may also contribute to stabiliz-
ing this arrangement. Thus, the internalized position of
the inner-lid loop within an enzyme-substrate complex
would explain the observation that L-Tyr inhibits proteo-
lytic cleavage at two sites along this loop inR. toruloides
PAL [17]. Comparison of the crystal structures of unli-
ganded and coumarate-complexed RsTAL indicates
that coumarate binding is accommodated within the ac-
tive site with no significant structural perturbation to the
surrounding protein. This observation is somewhat sur-
prising, in light of the close packing of residues around
the coumarate product and the closed lid-loops which
apparently occlude access to the active-site pocket.
These results suggest a dynamic role of the active-site
lid loops in substrate binding, sequestering of reaction
intermediates, and/or catalysis.
Chemistry & Biology
1334Figure 4. Product Complexes of H89F RsTAL
(A) Electron density and interactions of the cinnamate product bound in the active site of H89F RsTAL. For the Fobs 2 Fcalc electron-density
map (1.9 A˚ resolution and shown contoured at 2.5s), cinnamate and the side chain of Phe 89 were excluded from all calculations.
(B) Electron density and interactions of coumarate bound to the H89F RsTAL active site. For the Fobs 2 Fcalc electron-density map (2.0 A˚ res-
olution and shown contoured at 2.5s), coumarate and the side chain of Phe 89 were excluded from all calculations.
(C) Chemical structure of AIP.
(D) Electron density and interactions of the PAL inhibitor AIP bound covalently to the MIO cofactor of H89F RsTAL. For the Fobs 2 Fcalc elec-
tron-density map (1.75 A˚ resolution and shown contoured at 2.5s), AIP, MIO, and the side chain of Phe 89 were excluded from all calculations.
The residue labeled in red, Asn 203, is involved in a backbone conformational rearrangement that allows the Asn 203 side chain to engage the
MIO cofactor upon AIP binding.
(E) Comparison of the binding modes of cinnamate (yellow), coumarate (orange-tan), and AIP (cyan) with the H89F RsTAL active site. Also
shown is coumarate (magenta) bound to wild-type RsTAL, with the hydrogen-bonding interactions between the coumarate product and
wild-type RsTAL represented as green dashed lines.Implications for the Reaction Mechanism of RsTAL
The structures of the RsTAL-coumarate, -caffeate and
-cinnamate complexes allow for modeling of the binding
of the substrate L-Tyr (Figures 5C and 5D). A sizable
translational shift of the substrate would be requiredto bring the L-Tyr ring Cd atom (C2 relative to C4 bearing
the phenolic hydroxyl moiety) within bonding distance of
the MIO methylidene, as suggested by the Friedel-
Crafts-type mechanism [1]. Such a movement would dis-
rupt the interactions formed by the a-carboxylate and
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1335Figure 5. Active-Site Lid Loops and a Model for L-Tyr Binding to RsTAL
(A) Stereo comparison of the lid-loop conformations of RsTAL (green), PcPAL (blue), and PpHAL (magenta). Two panels, top (RsTAL versus
PcPAL) and bottom, (RsTAL versus PpHAL), are shown to simplify viewing. For each protein, the inner loops (RsTAL residues 53–81, PcPAL
residues 103–129, and PpHAL residues 46–74) are shown in darker shades, and the outer loops (RsTAL residues 268–300, PcPAL residues
325–351, and PpHAL residues 260–280) are shown in lighter shades. The side chains of two invariant aromatic residues from the inner loop
are shown (RsTAL Tyr 60 and Phe 66, PcPAL Tyr 110 and Phe 116, and PpHAL Tyr 53 and Phe 59).
(B) The RsTAL homotetramer in the vicinity of the active-site pocket of monomer a is shown in ribbon representation. The polypeptide chains
of the individual monomers are colored as in Figure 1A, with the active-site lid loops shaded darker (green, inner loop of monomer a; yellow,
outer loop of monomer d). The MIO cofactor, bound coumarate, and protein residues that interact with the coumarate are drawn as balls and
sticks and colored by atom type.
(C) The L-Tyr substrate (magenta) was modeled with minimal modifications from the binding mode of the coumarate product shown in
Figure 3B.
(D) The L-Tyr substrate was modeled based upon the binding mode of the AIP inhibitor shown in Figure 4D, which places the a-amino group
within covalent bonding distance of the Cb2 methylidene carbon of the MIO cofactor (yellow dashed line). Note that a hydrogen bond between
the L-Tyr-OH and the His 89-NE2 is preserved despite the shifted position of the L-Tyr substrate.para-hydroxylgroups toTAL (Figure3B).On the other hand,
although the substrate’s a-amino group in the modeled
complex is oriented away from the cofactor, a modestchange in conformation of the propenoate group would
position the a-amino group appropriately for attack on
the MIO methylidene carbon (Figures 5C and 5D).
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formed on the MIO carbonyl oxygen (O2) would be sta-
bilized by water-mediated protonation (enol tautomer)
in the oxyanion hole (Figure 2D) and a newly formed
interaction with the side-chain amide of Asn 203
(Figure 5D). Notably, Asn 203 is brought into proximity
of the cofactor by a rearrangement of the segment of
polypeptide-chain spanning residues 194–205 (as ob-
served in the TAL-AIP covalent complex) (Figure 4D).
Substitution of this highly conserved residue by Ala
causes large decreases in kcat in both HAL and PAL
[24, 25].
The covalent binding of the inhibitor AIP to H89F
RsTAL observed crystallographically here does not nec-
essarily support a mechanism beginning with amino-
directed attack. Nevertheless, AIP does serve as a
very useful geometrically constrained mimic of one
L-Phe conformer (Figures 4E and 5D). While this struc-
tural study does not unconditionally resolve the mecha-
nistic debate, the elucidation of these product and inhib-
itor complexes provides a useful structural perspective
for considering additional mechanistic alternatives to
the two currently described mechanisms.
Significance
The structures of RsTAL complexed with coumarate
provide definitive experimental pictures of substrate
or product binding to aromatic amino acid ammonia-
lyases. The binding of coumarate in the RsTAL active
site involves interactions of the propenoate moiety
with protein residues that are highly conserved in aro-
matic amino acid ammonia-lyases including Tyr 60
and Arg 303. The residues that interact with the aro-
matic ring are more variable, as expected, given the
differences in side-chain selectivities within the family
of MIO-dependent enzymes. Notably, the RsTAL
His89-imidazole group, which hydrogen bonds with
the coumarate p-hydroxyl moiety, discriminates
between L-Tyr and L-Phe or L-His as substrates. This
discovery is the selectivity filter in PAL/TAL/HALs. Re-
placement of His 89 by Phe, a residue more character-
istic of the PALs, yields a mutant RsTAL with a switch
in substrate preference from L-Tyr to L-Phe. Struc-
tures of the H89F mutant RsTAL in complex with the
reaction product, cinnamic acid, or the PAL inhibitor,
2-aminoindan-2-phosphonic acid, revealed binding
modes in which the phenyl rings of Phe 89 and the li-
gands interact edge to edge.Baseduponacomparison
of available X-ray crystal structures, it appears that
two loops capping the active site of the aromatic
amino acid ammonia-lyases play a role in both sub-
strate binding and catalysis. Our combined structural
and functional studies provide a starting point for un-
derstanding the reaction mechanism of this enzyme
family and also the aromatic amino acid aminomu-
tases, which biosynthesize b-amino acids in nature.
Engineering of alternative specificities in aromatic
amino acid ammonia-lyases and the related aminomu-
tases can now be undertaken using both site-directed
approaches and focused combinatorial methods to
expand the technological utility of these MIO-depen-
dent enzymes.Experimental Procedures
Synthetic Gene Expression and Purification,
and Mutagenesis of RsTAL
A synthetic gene encoding the amino acid sequence of RsTAL was
synthesized by GenScript (www.genscript.com). The gene se-
quence was optimized for codon preferences in Escherichia coli
and bracketed by 50-NcoI and 30-BamH1 restriction sites. The
gene was inserted between the NcoI and BamH1 sites of the expres-
sion vector pHIS8 under control of a T7 promoter to yield the tar-
get protein fused to a thrombin-cleavable N-terminal octahistidine
tag [26].
Briefly, E. coli cultures in TB medium were grown at 37C to an op-
tical density (600 nm) of 1.5, induced with 1 mM isopropyl-b-D-thio-
galactoside, and allowed to grow for an additional 6 hr at 20C. Bac-
terial cells were harvested by centrifugation, resuspended in lysis
buffer (50 mM TrisHCl [pH 8.0], 0.5 M NaCl, 20 mM imidazole, 1%
[v/v] Tween 20, 10% [v/v] glycerol and 20 mM 2-mercaptoethanol),
and lysed by sonication. RsTAL was isolated from the E. coli lysate
by affinity chromatography with Ni2+-NTA agarose and eluted with
lysis buffer supplemented with 0.25 M imidazole. Nearly homo-
geneous RsTAL was treated with thrombin for cleavage of the
octahistidine tag, and then further purified by gel-exclusion chroma-
tography using a Superdex 200 HR26/60 column (Pharmacia Bio-
systems). Site-directed mutants of the RsTAL gene were created
in the plasmid pHIS8-RsTAL using the QuikChange protocol (Strata-
gene), and mutant proteins were expressed and purified as de-
scribed for wild-typeRsTAL. The DNA sequences of the mutant con-
structs were confirmed by sequencing of the entire RsTAL gene
insert in both the forward and reverse directions.
Enzyme Assays
TAL activity was measured spectrophotometrically by monitoring
formation of a conjugated aryl-acid product. The conversion of
L-Tyr to p-coumarate was followed at 310 nm and that of L-Phe to
cinnamate at 280 nm. The assay mixture (total volume 0.5 ml) con-
tained 0.1 M TrisHCl (pH 8.5) and, for each fixed amount of TAL, eight
different initial concentrations of amino acid substrate. After prein-
cubation of the enzyme at 37C for 2 min, reactions were initiated
by the addition of substrate, and formation of product was moni-
tored for 5 min. For wild-type RsTAL, activity was assayed with
7.5 mg protein and initial L-Tyr concentrations between 0.01 and
2.4 mM, and PAL activity was assayed with 30 mg protein and initial
L-Phe concentrations between 3.2 and 51.2 mM. For the RsTAL
H89F mutant, PAL activity was assayed with 10 mg protein and initial
L-Phe concentrations between 0.05 and 5.2 mM. Each series of as-
says were performed in triplicate, and a Hanes plot was used for the
estimation of steady-state kinetic constants.
The inhibition of enzyme activity by AIP was measured with a sim-
ilar assay system, except that the enzyme was preincubated for
7 min in the presence of fixed concentrations of AIP. Inhibition of
PAL activity of wild-type RsTAL was measured with 15 mg protein,
six AIP concentrations between 0 and 20 mM, and initial L-Phe con-
centrations between 9.6 and 25.6 mM. Inhibition of PAL activity of
the H89F mutant was measured with 10 mg protein, five AIP con-
centrations between 0 and 5 mM, with initial L-Phe concentrations
between 0.4 and 1.6 mM. Duplicate sets of enzyme assays were
performed, and a Dixon plot was used for the estimation of the
AIP inhibition constant, Ki.
Crystallization and X-Ray Structure Elucidation of RsTAL
Crystals of RsTAL (space group P21) were grown from a 1:1 mixture
of protein solution (20 mg/ml in 12.5 mM Tris-HCl [pH 7.5], 50 mM
NaCl) and a reservoir solution (0.1 M MOPSO-Na+ [pH 7.0], 7%
[w/v] polyethylene glycol 8000, 0.3 M ammonium acetate, 2 mM di-
thiothreitol, 35 mM cyclohexylbutanoyl-N-hydroxyethylglucamide)
using vapor diffusion at 4C. Crystal growth occurred over a period
of 1–3 weeks and was expedited through microseeding. The crystals
exhibit a rhomboid morphology and grow to a maximum size of
0.4 3 0.1 3 0.1 mm. Crystals of RsTAL in complex with small-
molecule ligands were produced by soaking crystals for 24–48 hr
in reservoir solutions supplemented with 10–20 mM coumaric
acid, caffeic acid, cinnamic acid, or AIP.
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1337Crystals were transferred briefly to a cryo-protectant solution
(consisting of reservoir solution supplemented with 15%–20%
[v/v] polyethylene glycol 400) prior to immersion in liquid nitrogen.
X-ray diffraction data were measured from frozen crystals at
beamline 8.2.2 of the Advanced Light Source (Lawrence Berkeley
National Laboratory) on an ADSC Quantum 315 CCD detector or at
beamline 11.1 of the Stanford Synchrotron Radiation Laboratory
on an ADSC Quantum 315 CCD detector. Diffraction intensities
were indexed, integrated, and scaled with the programs XDS
and XSCALE [27], or Mosflm [28] and Scala [29], as summarized
in Table 1.
RsTAL crystals contain two complete homotetramers per asym-
metric unit and diffract up to 1.50 A˚ resolution. Initial phases were
determined by molecular replacement using the program Molrep
[30]. A homology model for RsTAL was constructed with the
program Modeller [31], based on the structure of P. putida HAL
(PDB entry 1GKM). The program ARP/wARP [32] was used for auto-
mated rebuilding of the initial structure using an 8-fold, noncrystallo-
graphic symmetry (NCS) averaged map. Subsequent structural
refinement used the program CNS [33] with NCS restraints applied
until the final stages where they were removed. Xfit [34] was used
for map inspection and manual rebuilding of the atomic model. Pro-
grams from the CCP4 suite [29] were employed for all other crystal-
lographic calculations. For refinement of the coumarate, caffeate,
and cinnamate molecules, no conformational restraints were ap-
plied to the freely rotatable dihedral angles of the propenoate moiety
or to enforce similarity of NCS-related copies. Figures were drawn
with the program Pymol (Delano Scientific, San Carlos, CA).
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